Home
News Open submenu
About MedNous Open submenu
Research Directory Open submenu
Contact Us Open submenu

Close submenu News

News
Appointments
Events

Close submenu About MedNous

Who We Are
Editorial Board
Editorial Policy

Close submenu Research Directory

Research Directory
Organisations
Interviewees
Terms
Topics

Close submenu Contact Us

Contact Form

Skip to main content

30 May 2025

Last updated: Thursday 29 May 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Technology for direct cell reprogramming

Tuesday 10 September 2019

Interviewee/Contributor

Julian Gough

Organisation

Mogrify Ltd

Organisations

BioLizard NV
Celtic Pharmaceutical Holdings LP
Galapagos NV
German Pharmaceutical Industry Association
Avacta Group Plc
Biophytis SA
Bone Therapeutics SA
Heptares Therapeutics Ltd
Massachusetts General Hospital
Boston Consulting Group

Interviewees and Contributers

Rudy Dekeyser
Wes Kim
Ravi Nalliah
John Lisman
Walter Schmidt
John Rountree
Gil Beyen
Moshik Cohen-Kutner and Niv Bachnoff
Patrik De Haes
Keith Flaherty

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Shift Bioscience makes two appointments

Tuesday 20 May 2025

Steven Johnson joins Zealand Pharma

Tuesday 20 May 2025

New CSO at Zealand Pharma

Friday 9 May 2025

Henry Gosebruch to lead Galapagos spin-out

Friday 9 May 2025

New CEO at TME Pharma NV

Friday 9 May 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.